Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhonggui He

Showing results (211-220 of 451) with videos related to

Pageof 46
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 19, 2023
Emerging platinum(IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapyShunzhe Zheng, Guanting Li, Jianbin Shi, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 1, 2016
Facile Fabrication of Tumor Redox-Sensitive Nanoassemblies of Small-Molecule Oleate Prodrug as Potent Chemotherapeutic NanomedicineCong Luo, Jin Sun, Bingjun Sun, et al.
International Journal of Pharmaceutics|May 24, 2026
Predicting the compressibility and compactibility profiles of pharmaceutical active ingredients for design of multi-component tabletsChuhong Cheng, Ke Wang, Walkiria Schlindwein, et al.
Drug Delivery|March 20, 2018
Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapyJincheng Yang, Qingzhi Lv, Wei Wei, et al.
Acta Biomaterialia|March 19, 2022
Iron ion-coordinated carrier-free supramolecular co-nanoassemblies of dual DNA topoisomerase-targeting inhibitors for tumor suppressionJianhuan Guan, Xiao Tan, Jian Jiao, et al.
International Journal of Pharmaceutics|September 16, 2016
Novel nanostructured enoxaparin sodium-PLGA hybrid carriers overcome tumor multidrug resistance of doxorubicin hydrochlorideJia Wang, Lei Wu, Longfa Kou, et al.
International Journal of Pharmaceutics|July 27, 2020
Single-ligand dual-targeting irinotecan liposomes: Control of targeting ligand display by pH-responsive PEG-shedding strategy to enhance tumor-specific therapy and attenuate toxicityZhenjie Wang, Xinxin Lin, Dongxu Chi, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 4, 2025
Galangin Nano-Cocktail Balances Prodrug Activation and Antitumor Response for Enhanced Cancer TreatmentCongtian Wu, Yuequan Wang, Ziqi Lin, et al.
Asian Journal of Pharmaceutical Sciences|May 18, 2022
Impact of the amount of PEG on prodrug nanoassemblies for efficient cancer therapyYaqiao Li, Lingxiao Li, Qianhui Jin, et al.
Biomaterials Science|December 20, 2016
ATB<sup>0,+</sup> transporter-mediated targeting delivery to human lung cancer cells via aspartate-modified docetaxel-loading stealth liposomesQiuhua Luo, Bin Yang, Wenhui Tao, et al.
Pageof 46

Showing results (211-220 of 451) with videos related to

Sort By:
Pageof 46
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 19, 2023
Emerging platinum(IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapyShunzhe Zheng, Guanting Li, Jianbin Shi, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 1, 2016
Facile Fabrication of Tumor Redox-Sensitive Nanoassemblies of Small-Molecule Oleate Prodrug as Potent Chemotherapeutic NanomedicineCong Luo, Jin Sun, Bingjun Sun, et al.
International Journal of Pharmaceutics|May 24, 2026
Predicting the compressibility and compactibility profiles of pharmaceutical active ingredients for design of multi-component tabletsChuhong Cheng, Ke Wang, Walkiria Schlindwein, et al.
Drug Delivery|March 20, 2018
Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapyJincheng Yang, Qingzhi Lv, Wei Wei, et al.
Acta Biomaterialia|March 19, 2022
Iron ion-coordinated carrier-free supramolecular co-nanoassemblies of dual DNA topoisomerase-targeting inhibitors for tumor suppressionJianhuan Guan, Xiao Tan, Jian Jiao, et al.
International Journal of Pharmaceutics|September 16, 2016
Novel nanostructured enoxaparin sodium-PLGA hybrid carriers overcome tumor multidrug resistance of doxorubicin hydrochlorideJia Wang, Lei Wu, Longfa Kou, et al.
International Journal of Pharmaceutics|July 27, 2020
Single-ligand dual-targeting irinotecan liposomes: Control of targeting ligand display by pH-responsive PEG-shedding strategy to enhance tumor-specific therapy and attenuate toxicityZhenjie Wang, Xinxin Lin, Dongxu Chi, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 4, 2025
Galangin Nano-Cocktail Balances Prodrug Activation and Antitumor Response for Enhanced Cancer TreatmentCongtian Wu, Yuequan Wang, Ziqi Lin, et al.
Asian Journal of Pharmaceutical Sciences|May 18, 2022
Impact of the amount of PEG on prodrug nanoassemblies for efficient cancer therapyYaqiao Li, Lingxiao Li, Qianhui Jin, et al.
Biomaterials Science|December 20, 2016
ATB<sup>0,+</sup> transporter-mediated targeting delivery to human lung cancer cells via aspartate-modified docetaxel-loading stealth liposomesQiuhua Luo, Bin Yang, Wenhui Tao, et al.
Pageof 46